labetalol has been researched along with Pheochromocytoma in 59 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The number of patients with intraoperative hypertension, number of patients receiving SNP, dose of SNP administered, and number of hypertension episodes were significantly lower in patients who received labetalol pretreatment than in control patients." | 9.12 | Labetalol pretreatment reduces blood pressure instability during surgical resection of pheochromocytoma. ( Chung, PC; Hsieh, JR; Li, AH; Ng, YT; Yang, MW, 2006) |
| "This case highlights the possibility of a more rapid perioperative control of pheochromocytoma using high doses of labetolol and a magnesium sulfate infusion to achieve stable intraoperative hemodynamics during laparoscopic resection of pheochromocytoma." | 7.71 | Rapid preparation of a patient with pheochromocytoma with labetolol and magnesium sulfate. ( Chin, EY; Poopalalingam, R, 2001) |
| "To report a case of pheochromocytoma exhibiting an increase in systemic vascular resistance index (SVRI) and decreased cardiac index (CI) after use of labetalol." | 7.71 | Elevated vascular resistance after labetalol during resection of a pheochromocytoma (brief report). ( Chung, PC; Li, AH; Lin, CC; Yang, MW, 2002) |
| "A case of intrahepatic metastatic pheochromocytoma with lymph nodes involvement undergoing resection of tumor was reported; intravenous labetalol in high dose regimen (2 mg/kg administered before skin incision) was used for blood pressure control during the operation." | 7.69 | High dose intravenous labetalol for the resection of metastatic pheochromocytoma. ( Chung, PC; Sum, DC; Wu, RS, 1996) |
| "A patient with pheochromocytoma was studied by MIBG scintigraphy while on labetalol therapy, which has been reported to interfere with imaging." | 7.68 | MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy. ( Bardies, M; Chatal, JF; Chetanneau, A; Kremer, M; Le Marec, H; Morais, J; Peltier, P, 1992) |
| "Labetalol, an alpha and beta adrenergic blocking drug, was used during anesthesia for removal of a very large pheochromocytoma which was predominantly epinephrine secreting." | 7.66 | Use of labetalol during anesthesia for pheochromocytoma removal. ( de Rood, M; Lambilliotte, JP; Levarlet, M; Lignian, H; Van Stratum, M, 1983) |
| "1 We have compared, in patients with severe hypertension, the administration of intravenous labetalol by single rapid injection, by repeated bolus injections, and by incremental infusion." | 7.66 | Intravenous labetalol in the treatment of severe hypertension. ( Brown, JJ; Cumming, AM; Lever, AF; Robertson, JI, 1982) |
| "Labetalol is an orally active adrenoceptor blocking drug which is a competitive antagonist at both alpha- and beta-adrenoceptor sites." | 6.36 | Labetalol: a review of its pharmacology and therapeutic use in hypertension. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| "Pheochromocytoma is a catecholamine-producing tumor but rarely delayingly diagnosed until during pregnancy." | 5.37 | Cardiovascular collapse after labetalol for hypertensive crisis in an undiagnosed pheochromocytoma during cesarean section. ( Huang, CS; Ko, YP; Kuok, CH; Tsai, PS; Yen, CR, 2011) |
| "Labetalol was used as antihypertensive agent and was given in repeated bolus (up to total dose of 2 mg/kg) intravenously before skin incision and no supplemental dosage was given later on." | 5.29 | Preliminary experience of using fixed dose of intravenous labetalol in surgical resection of pheochromocytoma. ( Chung, PC; Sum, DC, 1993) |
| "Labetalol is an antihypertensive agent with combined alpha- and beta-blocking properties that has been used to manage patients with suspected pheochromocytomas." | 5.28 | Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. ( Fig, LM; Khafagi, FA; Mallette, S; Shapiro, B; Sisson, JC, 1989) |
| "6 Labetalol is a useful addition to the medical treatment of phaeochromocytoma." | 5.26 | Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. ( Brown, JJ; Lever, AF; Robertson, AS; Robertson, JI; Rosei, EA; Trust, PM, 1976) |
| "The number of patients with intraoperative hypertension, number of patients receiving SNP, dose of SNP administered, and number of hypertension episodes were significantly lower in patients who received labetalol pretreatment than in control patients." | 5.12 | Labetalol pretreatment reduces blood pressure instability during surgical resection of pheochromocytoma. ( Chung, PC; Hsieh, JR; Li, AH; Ng, YT; Yang, MW, 2006) |
| " It has also been used intravenously in phaeochromocytoma, tetanus, clonidine withdrawal, and as an adjunct to halothane to produce hypotensive anaesthesia." | 4.76 | Combined alpha- and beta-receptor inhibition in the treatment of hypertension. ( Prichard, BN, 1984) |
| "This case highlights the possibility of a more rapid perioperative control of pheochromocytoma using high doses of labetolol and a magnesium sulfate infusion to achieve stable intraoperative hemodynamics during laparoscopic resection of pheochromocytoma." | 3.71 | Rapid preparation of a patient with pheochromocytoma with labetolol and magnesium sulfate. ( Chin, EY; Poopalalingam, R, 2001) |
| "To report a case of pheochromocytoma exhibiting an increase in systemic vascular resistance index (SVRI) and decreased cardiac index (CI) after use of labetalol." | 3.71 | Elevated vascular resistance after labetalol during resection of a pheochromocytoma (brief report). ( Chung, PC; Li, AH; Lin, CC; Yang, MW, 2002) |
| "A 22-year-old woman diagnosed with pheochromocytoma was medically managed at 33 weeks gestation with oral phenoxybenzamine and labetalol until delivery 26 days later." | 3.69 | Phenoxybenzamine placental transfer during the third trimester. ( Santeiro, ML; Stromquist, C; Wyble, L, 1996) |
| "A case of intrahepatic metastatic pheochromocytoma with lymph nodes involvement undergoing resection of tumor was reported; intravenous labetalol in high dose regimen (2 mg/kg administered before skin incision) was used for blood pressure control during the operation." | 3.69 | High dose intravenous labetalol for the resection of metastatic pheochromocytoma. ( Chung, PC; Sum, DC; Wu, RS, 1996) |
| "A patient with pheochromocytoma was studied by MIBG scintigraphy while on labetalol therapy, which has been reported to interfere with imaging." | 3.68 | MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy. ( Bardies, M; Chatal, JF; Chetanneau, A; Kremer, M; Le Marec, H; Morais, J; Peltier, P, 1992) |
| "Labetalol, an alpha and beta adrenergic blocking drug, was used during anesthesia for removal of a very large pheochromocytoma which was predominantly epinephrine secreting." | 3.66 | Use of labetalol during anesthesia for pheochromocytoma removal. ( de Rood, M; Lambilliotte, JP; Levarlet, M; Lignian, H; Van Stratum, M, 1983) |
| "1 We have compared, in patients with severe hypertension, the administration of intravenous labetalol by single rapid injection, by repeated bolus injections, and by incremental infusion." | 3.66 | Intravenous labetalol in the treatment of severe hypertension. ( Brown, JJ; Cumming, AM; Lever, AF; Robertson, JI, 1982) |
| "A preoperative patient with pheochromocytoma was satisfactorily treated with oral labetalol, while a conspicuous increase in urinary output of catecholamines (CA) and of vanillylmandelic acid (VMA) was observed after labetalol therapy." | 3.66 | Falsely high urinary catecholamines induced by labetalol. ( Abe, K; Adachi, M; Kobayashi, K; Miura, Y; Sakuma, H; Tomioka, H; Yoshinaga, K, 1979) |
| "The dosage of urinary catecholamines and their metabolites is a main element of diagnosis in the research of a pheochromocytoma in patients with high blood pressure." | 2.67 | [Absence of labetalol interference on urine metanephrine determination in hypertensive patients]. ( Billaud, EM; Girerd, X; Laurent, S; Ropers, J; Safar, M; Safavian, A; Sorrel-Dejerine, A, 1992) |
| "Labetalol is a unique antihypertensive agent which is a competitive peripheral antagonist at both alpha- and beta-adrenoceptor sites." | 2.37 | Current status of labetalol, the first alpha- and beta-blocking agent. ( Kanto, JH, 1985) |
| "Labetalol is an orally active adrenoceptor blocking drug which is a competitive antagonist at both alpha- and beta-adrenoceptor sites." | 2.36 | Labetalol: a review of its pharmacology and therapeutic use in hypertension. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| "Giant pheochromocytomas are rare tumors, with the majority being clinically silent." | 1.91 | A Giant Pheochromocytoma Presenting in Pheochromocytoma Crisis: A Case Report. ( Baniya, S; Bogati, K; Karki, N; Pokhrel, M; Regmi, UK; Thapa, S, 2023) |
| "Pheochromocytoma is a catecholamine-producing tumor but rarely delayingly diagnosed until during pregnancy." | 1.37 | Cardiovascular collapse after labetalol for hypertensive crisis in an undiagnosed pheochromocytoma during cesarean section. ( Huang, CS; Ko, YP; Kuok, CH; Tsai, PS; Yen, CR, 2011) |
| "Labetalol was used as antihypertensive agent and was given in repeated bolus (up to total dose of 2 mg/kg) intravenously before skin incision and no supplemental dosage was given later on." | 1.29 | Preliminary experience of using fixed dose of intravenous labetalol in surgical resection of pheochromocytoma. ( Chung, PC; Sum, DC, 1993) |
| "Labetalol is an antihypertensive agent with combined alpha- and beta-blocking properties that has been used to manage patients with suspected pheochromocytomas." | 1.28 | Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. ( Fig, LM; Khafagi, FA; Mallette, S; Shapiro, B; Sisson, JC, 1989) |
| "6 Labetalol is a useful addition to the medical treatment of phaeochromocytoma." | 1.26 | Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. ( Brown, JJ; Lever, AF; Robertson, AS; Robertson, JI; Rosei, EA; Trust, PM, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (64.41) | 18.7374 |
| 1990's | 11 (18.64) | 18.2507 |
| 2000's | 8 (13.56) | 29.6817 |
| 2010's | 1 (1.69) | 24.3611 |
| 2020's | 1 (1.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bogati, K | 1 |
| Baniya, S | 1 |
| Thapa, S | 1 |
| Regmi, UK | 1 |
| Karki, N | 1 |
| Pokhrel, M | 1 |
| Asencio Moreno, A | 1 |
| Alamán Orbañanos, B | 1 |
| Moro Velasco, MC | 1 |
| Kuok, CH | 1 |
| Yen, CR | 1 |
| Huang, CS | 1 |
| Ko, YP | 1 |
| Tsai, PS | 1 |
| Kai, H | 1 |
| Imaizumi, T | 1 |
| Chung, PC | 4 |
| Ng, YT | 1 |
| Hsieh, JR | 1 |
| Yang, MW | 2 |
| Li, AH | 2 |
| Lewis, S | 1 |
| Dirnhuber, M | 1 |
| Soar, J | 1 |
| Hiéronimus, S | 1 |
| Bernard, JL | 1 |
| Chevallier, P | 1 |
| Chevallier, A | 1 |
| Chyderiotis, G | 1 |
| Fenichel, P | 1 |
| Landraud, L | 1 |
| Noppers, IM | 1 |
| Zijlstra, JG | 1 |
| Russell, WJ | 2 |
| Kaines, AH | 1 |
| Hooper, MJ | 1 |
| Frewin, DB | 2 |
| Prichard, BN | 1 |
| van Hasselt, G | 1 |
| MacKenzie, I | 1 |
| Edwards, JC | 1 |
| Reid, JL | 1 |
| Meredith, PA | 1 |
| Elliott, HL | 1 |
| Yoshinaga, K | 3 |
| Arakawa, K | 2 |
| Ando, H | 1 |
| Iai, F | 1 |
| Ikeda, M | 3 |
| Sugano, O | 1 |
| Hirano, J | 1 |
| Hirano, K | 1 |
| Kubota, Y | 1 |
| Numasawa, K | 1 |
| Kawamura, S | 1 |
| Navaratnarajah, M | 1 |
| White, DC | 1 |
| Enoki, N | 1 |
| Satoh, Z | 1 |
| Ogata, A | 1 |
| Yukioka, H | 1 |
| Nishimura, K | 1 |
| Fujimori, M | 1 |
| Galletly, DC | 1 |
| Yee, P | 1 |
| Maling, TJ | 1 |
| Van Stratum, M | 1 |
| Levarlet, M | 1 |
| Lambilliotte, JP | 1 |
| Lignian, H | 1 |
| de Rood, M | 1 |
| Stewart, PA | 1 |
| Robertson, JI | 6 |
| Cumming, AM | 1 |
| Brown, JJ | 5 |
| Lever, AF | 5 |
| Ebihara, T | 1 |
| Oe, N | 1 |
| Reach, G | 1 |
| Thibonnier, M | 1 |
| Chevillard, C | 1 |
| Corvol, P | 1 |
| Milliez, P | 1 |
| Feek, CM | 1 |
| Earnshaw, PM | 1 |
| Sheaves, R | 1 |
| Chew, SL | 1 |
| Grossman, AB | 1 |
| Apeldoorn, L | 1 |
| Voerman, HJ | 1 |
| Hoefnagel, CA | 1 |
| Sum, DC | 2 |
| Santeiro, ML | 1 |
| Stromquist, C | 1 |
| Wyble, L | 1 |
| Wu, RS | 1 |
| Metcalfe, IR | 1 |
| Tonkin, AL | 1 |
| Armero, R | 1 |
| Vicente, R | 1 |
| Alepuz, R | 1 |
| Poopalalingam, R | 1 |
| Chin, EY | 1 |
| Lin, CC | 1 |
| Rosei, EA | 4 |
| Fraser, R | 2 |
| Morton, JJ | 2 |
| Trust, PM | 4 |
| Brogden, RN | 1 |
| Heel, RC | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Briggs, RS | 1 |
| Birtwell, AJ | 1 |
| Pohl, JE | 1 |
| FitzGerald, GA | 1 |
| Lax, P | 1 |
| Ruthven, CR | 1 |
| Sandler, M | 1 |
| Nyberg, G | 1 |
| Waldenström, J | 1 |
| Vedin, A | 1 |
| Bailey, RR | 1 |
| Kaufman, L | 1 |
| Chapman, BP | 1 |
| Veitch, AG | 1 |
| Shepherd, B | 1 |
| Kobayashi, K | 1 |
| Miura, Y | 1 |
| Tomioka, H | 1 |
| Sakuma, H | 1 |
| Adachi, M | 1 |
| Abe, K | 1 |
| Robertson, AS | 2 |
| Girerd, X | 1 |
| Billaud, EM | 1 |
| Sorrel-Dejerine, A | 1 |
| Ropers, J | 1 |
| Safavian, A | 1 |
| Safar, M | 1 |
| Laurent, S | 1 |
| Morais, J | 1 |
| Le Marec, H | 1 |
| Peltier, P | 1 |
| Chetanneau, A | 1 |
| Kremer, M | 1 |
| Bardies, M | 1 |
| Chatal, JF | 1 |
| Sheps, SG | 1 |
| Jiang, NS | 1 |
| Klee, GG | 1 |
| van Heerden, JA | 1 |
| Crawford, GA | 1 |
| Györy, AZ | 1 |
| Gallery, ED | 1 |
| Kelly, D | 1 |
| Khafagi, FA | 1 |
| Shapiro, B | 1 |
| Fig, LM | 1 |
| Mallette, S | 1 |
| Sisson, JC | 1 |
| Pelegrí, A | 1 |
| Romero, R | 1 |
| Reguant, M | 1 |
| Aisa, L | 1 |
| Kanto, JH | 1 |
| Yabe, R | 1 |
| Suenaga, K | 1 |
| Niimura, S | 1 |
| Itoh, N | 1 |
| Tani, M | 1 |
| Kunii, N | 1 |
| Watari, H | 1 |
| Yatabe, Y | 1 |
| Mizuno, K | 1 |
| Fukuchi, S | 1 |
| Blom, HJ | 1 |
| Karsdorp, V | 1 |
| Birnie, R | 1 |
| Davies, G | 1 |
| Debache, N | 1 |
| Bleinc, D | 1 |
| Touboul, A | 1 |
| Haquin, G | 1 |
| Chouty, F | 1 |
| Lardoux, H | 1 |
| Sheikh, A | 1 |
| Kojima, S | 1 |
| Natsume, T | 1 |
| Ito, K | 1 |
| Bouloux, PM | 1 |
| Featherstone, RM | 1 |
| Clement-Jones, V | 1 |
| Rees, LH | 1 |
| Goligher, JE | 1 |
6 reviews available for labetalol and Pheochromocytoma
| Article | Year |
|---|---|
[Protective effect of alpha beta-blockers on hypertensive target-organ damage].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive | 2004 |
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihyp | 1984 |
Labetalol and the management of hypertension.
Topics: Adrenal Gland Neoplasms; Clonidine; Ethanolamines; Humans; Hypertension; Labetalol; Pheochromocytoma | 1981 |
Labetalol: a review of its pharmacology and therapeutic use in hypertension.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; | 1978 |
Recent developments in the diagnosis and treatment of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Humans; Labetalol; Methyltyrosines; Pheochromocytoma; | 1990 |
Current status of labetalol, the first alpha- and beta-blocking agent.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Biot | 1985 |
3 trials available for labetalol and Pheochromocytoma
| Article | Year |
|---|---|
Labetalol pretreatment reduces blood pressure instability during surgical resection of pheochromocytoma.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hypertension; Infusions, | 2006 |
[Clinical effects of labetalol on pheochromocytoma].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Clinical Trials as Topic; Ethanolamines; Female; H | 1983 |
[Absence of labetalol interference on urine metanephrine determination in hypertensive patients].
Topics: Adrenal Gland Neoplasms; Adult; Aged; Chromatography, Liquid; Female; Humans; Hypertension; Labetalo | 1992 |
50 other studies available for labetalol and Pheochromocytoma
| Article | Year |
|---|---|
A Giant Pheochromocytoma Presenting in Pheochromocytoma Crisis: A Case Report.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Middle Ag | 2023 |
[Anesthesia for the surgical removal of bilateral pheochromocytomas during the second trimester of pregnancy].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Anesthesia, Epidural; Anesthesia, Gene | 2009 |
Cardiovascular collapse after labetalol for hypertensive crisis in an undiagnosed pheochromocytoma during cesarean section.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Cesarean Section; Female; Humans; Hyper | 2011 |
An unusual presentation of a pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Humans; Hypertension; Labetalol; Male; Middle Aged; Pheochromocytoma | 2006 |
Adrenal tuberculosis after a pheochromocytoma: a misleading tumoral presentation.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Anti-Inflammatory Age | 2007 |
Undulating blood pressure.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Antihypertensive Agents; Blood Pressure; Fem | 2008 |
Labetalol in the preoperative management of phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Dopamine; Epinephrine; Ethano | 1982 |
Use of vecuronium and labetalol in patients with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Anesthesia; Humans; Hypertension; Jaw Fractures; Labetalol; Male; Pa | 1984 |
[Malignant pheochromocytoma: blood pressure controlled by labetalol].
Topics: Adrenal Gland Neoplasms; Adult; Ethanolamines; Humans; Hypertension; Labetalol; Male; Pheochromocyto | 1984 |
Labetalol and phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Ethanolamines; Female; Humans; Hypertension; Labetalol; Pheochromocytoma | 1984 |
[Hypertensive response to labetalol in pheochromocytoma].
Topics: Adrenal Cortex Neoplasms; Anesthesia, Intravenous; Ethanolamines; Female; Humans; Hypertension; Labe | 1984 |
Anaesthetic management of combined caesarean section and phaeochromocytoma removal.
Topics: Adrenal Gland Neoplasms; Adult; Anesthesia, General; Atenolol; Cesarean Section; Female; Humans; Lab | 1983 |
Use of labetalol during anesthesia for pheochromocytoma removal.
Topics: Adrenal Gland Neoplasms; Aged; Anesthesia; Epinephrine; Ethanolamines; Female; Humans; Hypertension; | 1983 |
Adrenal phaeochromocytoma in familial neurofibromatosis with initial control of hypertension by labetalol.
Topics: Adrenal Gland Neoplasms; Female; Humans; Hypertension; Labetalol; Middle Aged; Neurofibromatosis 1; | 1982 |
Labetalol: the nineteen-eighties.
Topics: Adrenal Gland Neoplasms; Anesthesia; Coronary Disease; Ethanolamines; Female; Humans; Hypertension; | 1982 |
Intravenous labetalol in the treatment of severe hypertension.
Topics: Adrenal Gland Neoplasms; Catecholamines; Clonidine; Ethanolamines; Humans; Hypertension; Infusions, | 1982 |
[Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Ethanolamines; Female; Humans; Labetalol; Male; Mi | 1981 |
Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Epinephrine; Ethanolamines; Heart Rate; Humans; Labetalol; | 1980 |
Hypertensive response to labetalol in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Ethanolamines; Humans; Labetalol; Male; Middle Aged; Pheoch | 1980 |
The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Fatal Outcome; Female; Humans; L | 1995 |
Interference of MIBG uptake by medication: a case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnosis, Differential; Drug Intera | 1995 |
Preliminary experience of using fixed dose of intravenous labetalol in surgical resection of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Anesthesia; Blood Pressure; Heart Rate; Humans; Injections, In | 1993 |
Phenoxybenzamine placental transfer during the third trimester.
Topics: Adrenal Gland Neoplasms; Adult; Antihypertensive Agents; Female; Fetal Blood; Humans; Hypertension; | 1996 |
High dose intravenous labetalol for the resection of metastatic pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Blood Pressure; Humans; Injections, Intravenous; L | 1996 |
The preoperative management of phaeochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Female; Hu | 1998 |
[Use of labetalol in the anesthetic management of pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adult; Antihypertensive Agents; Carcinoma, Medullary; Humans; Hypertension; | 1999 |
Rapid preparation of a patient with pheochromocytoma with labetolol and magnesium sulfate.
Topics: Adult; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Intraoperative Period; Labetalol | 2001 |
Elevated vascular resistance after labetalol during resection of a pheochromocytoma (brief report).
Topics: Adrenal Gland Neoplasms; Adult; Antihypertensive Agents; Cardiac Output; Humans; Labetalol; Male; Ph | 2002 |
Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Ethanolamines; Humans; Hy | 1977 |
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensin II; Cloni | 1976 |
Hypertensive response to labetalol in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Ethanolamines; Female; Humans; Hypertension; Labetalol; Mid | 1978 |
Hypertensive response to labetalol in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Ethanolamines; Humans; Hypertension; Labetalol; Pheochromocytoma; Receptors | 1978 |
Labetalol and urinary metadrenalines.
Topics: Adrenal Gland Neoplasms; Epinephrine; Ethanolamines; Humans; Labetalol; Metanephrine; Normetanephrin | 1979 |
[Pheochromocytoma treated with combined alpha-beta blockader].
Topics: Adrenal Gland Neoplasms; Aged; Ethanolamines; Humans; Labetalol; Male; Pheochromocytoma | 1979 |
Labetalol in the treatment of a patient with phaechromocytoma: a case report.
Topics: Adrenal Gland Neoplasms; Blood Pressure; Child; Ethanolamines; Female; Humans; Hypertension; Injecti | 1979 |
Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Anesthesia; Ethanolamines; Female; Heart Rate; Humans; H | 1979 |
Labetalol and urinary catecholamines.
Topics: Catecholamines; Ethanolamines; Humans; Labetalol; Mandelic Acids; Pheochromocytoma | 1978 |
Falsely high urinary catecholamines induced by labetalol.
Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Ethanolamines; False Positive Reactions; Female; Hum | 1979 |
Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
Topics: Administration, Oral; Adult; Clonidine; Drug Evaluation; Ethanolamines; Female; Humans; Hypertension | 1976 |
Letter: Emergency treatment of hypertensive crisis following clonidine withdrawal.
Topics: Clonidine; Humans; Hypertension; Labetalol; Pheochromocytoma; Substance Withdrawal Syndrome | 1976 |
MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Humans; Iodine Radioisotopes; Iodobenzenes; L | 1992 |
HPLC of urinary catecholamines in the presence of labetalol, captopril, and alpha-methyldopa.
Topics: Adrenal Gland Neoplasms; Captopril; Catecholamines; Chromatography, High Pressure Liquid; False Posi | 1990 |
Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Drug Int | 1989 |
Non-resectable phaeochromocytoma: long term follow-up.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Aortography; Female; | 1989 |
Treatment of pheochromocytoma with dilevalol.
Topics: Administration, Oral; Blood Pressure; Female; Humans; Labetalol; Middle Aged; Pheochromocytoma | 1987 |
Phaeochromocytoma as a cause of pulmonary oedema.
Topics: Adrenal Gland Neoplasms; Adult; Humans; Labetalol; Male; Pheochromocytoma; Pulmonary Edema | 1987 |
[Pheochromocytoma and myocardial infarction (apropos of a case in a 34-year-old man)].
Topics: Adrenal Gland Neoplasms; Adult; Humans; Hypertension; Labetalol; Male; Myocardial Infarction; Pheoch | 1986 |
Use of atracurium and labetalol in a patient with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Atracurium; Female; Humans; Hypertension; Intraoperative Complicatio | 1986 |
Rapid cyclic fluctuations of blood pressure associated with treatment of pheochromocytoma by labetalol.
Topics: Administration, Oral; Adrenal Gland Neoplasms; Blood Pressure; Humans; Labetalol; Male; Middle Aged; | 1985 |
Erroneous diagnosis of phaeochromocytoma in hypertensive patient on labetalol.
Topics: Adrenal Gland Neoplasms; Diagnostic Errors; Ethanolamines; Humans; Hypertension; Labetalol; Male; Mi | 1985 |